ClearPoint Neuro CLPT Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about ClearPoint Neuro's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ClearPoint Neuro's common stock, shares authorized (in shares)?
- ClearPoint Neuro (CLPT) reported common stock, shares authorized (in shares) of $90M in Q1 2026.
- How has ClearPoint Neuro's common stock, shares authorized (in shares) changed year-over-year?
- ClearPoint Neuro's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $90M to $90M.
- What is the long-term trend for ClearPoint Neuro's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), ClearPoint Neuro's common stock, shares authorized (in shares) has grown at a -14.8% compound annual growth rate (CAGR), from $200M to $90M.